(Q48489238)

12 February 2018

title

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. (English)

1 reference

12 February 2018

enzyme replacement therapy

main subject

0 references

1 reference

Monica Sifuentes

1

1 reference

12 February 2018

Robin Doroshow

2

1 reference

12 February 2018

Richard Hoft

3

1 reference

12 February 2018

Greg Mason

4

1 reference

12 February 2018

Irwin Walot

5

1 reference

12 February 2018

Michael Diament

6

1 reference

12 February 2018

Susan Okazaki

7

1 reference

12 February 2018

Kenneth Huff

8

1 reference

12 February 2018

Gerald F Cox

9

1 reference

12 February 2018

Stuart J Swiedler

10

1 reference

12 February 2018

Emil D Kakkis

11

1 reference

12 February 2018

publication date

29 September 2006

1 reference

12 February 2018

Molecular Genetics and Metabolism

published in

1 reference

12 February 2018

volume

90

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

171-180

1 reference

12 February 2018

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

The eye as a window to inborn errors of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

Enzyme-replacement therapy in mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

Disordered breathing during sleep in patients with mucopolysaccharidoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.007

10.1016/J.YMGME.2006.08.007

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018